About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Articles

Erratum: Inhaled Nitric Oxide in Patients with Cardiogenic Shock Treated with Veno-arterial Extracorporeal Membrane Oxygenation and Impella

Published:

09 July 2024

Citation:

Journal of Asian Pacific Society of Cardiology 2024;3:e28.

Spironolactone versus Eplerenone for Resistant Hypertension

Published:

24 April 2024

Citation:

Journal of Asian Pacific Society of Cardiology 2024;3:e12.

Inhaled NO During ECPELLA Support

Published:

27 October 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e38.

Association Between Coronary Artery Calcium Score and Left Ventricular Diastolic Dysfunction in Patients with Hypertension

Published:

26 September 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e35.